Analytical Chemistry · 2021 · 42 citations · 38 references
Life SciencesNeurologyNeuroscienceNanobiotechnologyNanomaterialsNanotechnologyAmyloid FormationFluorescence MicroscopyNanomedicineOptical TweezersAmyloid Oligomer FormationNanoparticle Imaging AgentsNanoparticle Imaging ProbesNanoparticle-based ProbesNanoparticlesPhotoinduced LuminescenceUpconversion LuminescenceUpconversion Nanoparticles
Alzheimer’s disease (AD), known as a progressive neurodegenerative disorder, has had a terrible impact on the health of aged people. Due to its severity, early diagnosis of AD is significant to retard the progress and provide timely treatment. Here, we report a fluorescence ratio detection of AD biomarker amyloid β oligomers (AβOs) by combining highly doped upconversion nanoparticles-SiO2@metal–organic framework/black hole quencher (H-USM/BHQ-1) microspheres with optical tweezer (OT) microscopic imaging. Optical trapping a single microsphere not only avoids the interference of fluid viscosity but also provides a high power density laser source to efficiently stimulate upconversion luminescence (UCL) of highly doped upconversion nanoparticles (H-UCNPs). Under this condition, H-UCNPs show stronger UCL and greater power-dependent properties compared to low-doped ones. Moreover, the closely packed quenching molecules BHQ-1 on a metal–organic framework (ZIF-8) exhibit excellent quenching efficiency for upconversion 525 and 540 nm emission. Also, the luminescent resonance energy transfer efficiency reaches 89.58%. When different concentrations of AβOs are present, the UCL540 recovers due to the decomposition of ZIF-8 and the release of BHQ-1. Using 540 and 654 nm emission ratio of highly doped UCNPs as reporters, the limit of detection reaches 28.4 pM for the quantitative determination of AβOs. Besides, this strategy is able to selectively quantify the AβO concentration. Therefore, we demonstrated the combination of optical trapping and highly doped UCNPs which is applied for the detection of AβOs with high sensitivity and specificity.
38
Single-cell transcriptomic analysis of Alzheimer’s disease
Hansruedi Mathys, José Dávila-Velderrain, Zhuyu Peng et al. · Nature · 2019 · 2.7K citations · Full text
Diagnosis of Alzheimer's Disease
Zaven S. Khachaturian · Archives of Neurology · 1985 · 2.5K citations
Medicine, Neurology, Psychiatry +13
Mild Cognitive Impairment Represents Early-Stage Alzheimer Disease
Martha Storandt, J. Philip Miller, Daniel W. McKeel et al. · Archives of Neurology · 2001 · 1.9K citations
Structural variation in amyloid-β fibrils from Alzheimer's disease clinical subtypes
Wei Qiang, Wai‐Ming Yau, Junxia Lu et al. · Nature · 2017 · 643 citations
NIR II-responsive photon upconversion through energy migration in an ytterbium sublattice
Bo Zhou, Jinshu Huang, Xuelong Liu et al. · Nature Photonics · 2020 · 373 citations